England's Aesthetics Licensing Scheme: What's Actually Confirmed in 2026?
If you've seen a headline this year claiming cosmetic treatments in England are now “licensed” or “banned”, you'd be forgiven for thinking the rules have already changed. They haven't, not yet. Scotland has passed its own law. England is still working through consultation. Here is what is genuinely confirmed, what is still sitting on paper, and what it actually means if you are booking treatment with us in Bakewell this autumn.
Key takeaways, for anyone short on time:
England's proposed scheme uses a green, amber and red risk-based licensing model. It is government policy, not yet law.
The highest-risk procedures are expected to move under Care Quality Commission (CQC) regulation. No statutory instrument has been made as of September 2026.
Scotland has already passed comparable legislation, with practices there given until September 2027 to comply before offences take effect.
Prescription-only medicines will continue to be regulated by the MHRA regardless of the outcome, and can only be prescribed following a face-to-face clinical assessment.
A CQC-registered, consultation-led clinic already meets a higher bar than the proposed minimum, and that is not going to change.
Why the regulatory picture feels confusing right now
Part of the confusion is that aesthetic medicine in the UK is not governed by one regulator, but by several overlapping ones. A practitioner needs a professional registration, such as the Nursing and Midwifery Council (NMC), the General Medical Council (GMC) or the General Dental Council (GDC). A registered healthcare setting is separately overseen by the Care Quality Commission in England, or its equivalents in Scotland, Wales and Northern Ireland. On top of that sit practice-standards bodies such as the Joint Council for Cosmetic Practitioners (JCCP), Save Face and the ACE Group, the medicines regulator (MHRA), the clinical evidence body (NICE), and the advertising regulator (ASA), which polices how any of this can be marketed.
That is five or six different bodies, each with its own remit, and none of them the single “licensing scheme” that headlines tend to describe. The government's proposal adds a further, risk-based licensing layer on top of all of it, rather than replacing what already exists.
What's actually confirmed so far
The Department of Health and Social Care has set out its intention to introduce a licensing scheme for non-surgical cosmetic procedures in England, built around a green, amber and red risk tier. Lower and medium-risk treatments would sit under a new licensing regime. The highest-risk procedures are expected to move into CQC regulation, meaning they could only be carried out by specified regulated healthcare professionals in an appropriately regulated setting.
As things stand in September 2026, this remains confirmed government policy rather than force of law. No statutory instrument implementing the scheme has been made, and a further consultation on the detail is expected during the year before anything is brought into effect.
Scotland has moved faster. The Scottish Parliament has passed legislation requiring certain higher-risk non-surgical procedures to be performed by, or alongside, a registered healthcare professional in a registered setting, and prohibiting non-surgical cosmetic procedures for under-18s outright. Practices there have until at least September 2027 to bring themselves into line before enforcement begins.
What's still genuinely open
Several details have not yet been settled for England: exactly which treatments sit in which risk tier, how enforcement will work in practice, what the transition period will look like for existing practitioners, and a firm timetable for when any of it becomes law. Anyone telling you the English scheme is already in force, or naming a specific commencement date, is getting ahead of where the policy actually stands.
What this means if you're booking with us now
Because Haus of Ästhetik is already CQC-registered and run on a consultation-led model, a named clinician, a full medical history, and documented suitability assessment before any treatment, we are already operating to a standard that sits above the proposed minimum. Whatever form the English scheme eventually takes, we do not expect it to change how we work with you. It is, in effect, catching the wider industry up to where regulated clinics already are.
If you are choosing between clinics anywhere in the UK, CQC registration (or the equivalent in Scotland, Wales or Northern Ireland), named prescriber accountability, and a genuine face-to-face consultation are the things worth checking for today, regardless of what any future licensing scheme eventually requires.
Frequently asked questions
Is dermal filler regulated by the MHRA? Dermal filler is classified as a CE or UKCA-marked medical device, not a licensed medicine, so it sits under different regulatory routes to prescription-only injectables. It is not “MHRA-approved” in the way a medicine is, though the devices themselves must meet UK conformity requirements.
Does the proposed licensing scheme affect prescription-only injectable treatments? Prescription-only medicines are already restricted to prescribers who have assessed you face-to-face. Any future licensing scheme would sit alongside that existing medicines regulation, not replace it.
When will the English scheme become law? There is no confirmed date as of September 2026. Government has signalled a further consultation on the detail before anything is brought into force, so timing remains genuinely open.
This article is general skincare information and is not a substitute for individual medical advice. Any treatment is provided only after a personal consultation and suitability assessment. Haus of Ästhetik, Bakewell, Derbyshire.
Comments